Goodwin Procter has hired licensing partner Adam Bellack from Hogan Lovells as the firm continues to expand its life sciences practice.
Bellack joins as a partner in Goodwin’s Washington DC office, where he will advise clients in the life sciences and healthcare industries on licensing, collaborations and other strategic and commercial transactions. Those clients include start-ups and early-stage biotech companies, as well as established global pharma and medical device companies.
Mitchell Bloom, chair of Goodwin’s life sciences practice, said: “Having licensing lawyers of Adam’s calibre on board is invaluable to the growing number of our clients with therapeutics approaching commercialisation, and reinforces our practice as the global destination for the life sciences industry… [his experience] adds significant depth to our practice as Goodwin continues to partner with clients at the intersection of capital and innovation.”
Bellack had been at Hogan Lovells since 2007, where he was co-head of the firm’s life sciences transactions team for the Americas.
His arrival is the latest in a series of hires over the past three months, including healthcare partners Delphine O’Rourke and Brian Bewley, and life sciences IP partner Sabrina Poulos.
O’Rourke joined Goodwin in New York from Duane Morris in August, having previously worked in-house at a number of healthcare businesses, including most recently as associate general counsel at US faith-based medical company Ascension. Bewley also arrived in August, joining the firm’s Washington DC office. He was previously at Bass Berry & Sims in Nashville. Poulos, meantime, joined the firm’s San Francisco office in July from Wilson Sonsini Goodrich & Rosati.
Last month, Goodwin strengthened its London practice with the addition of a five-partner team of private equity lawyers from Sidley Austin. Goodwin was ranked third in Mergermarket’s 3Q20 global private equity buyout league table by deal count, having worked on 57 deals in the first nine months of the year.
Back in April, Goodwin said it was cutting the size of its global operations team in response to the coronavirus pandemic. It said it was making a ‘limited number’ of layoffs, but didn’t say exactly how many. The firm made more than $1bn in revenue last year.